Atria Investments’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $201K | Sell |
1,031
-3,741
| -78% | -$775K | ﹤0.01% | 2065 |
|
|
2026
Q1 | $1.07M | Buy |
4,772
+3,228
| +209% | +$804K | 0.01% | 1018 |
|
|
2025
Q4 | $372K | Sell |
1,544
-186
| -11% | -$47.6K | ﹤0.01% | 1624 |
|
|
2025
Q3 | $474K | Buy |
1,730
+50
| +3% | +$13.7K | 0.01% | 1442 |
|
|
2025
Q2 | $433K | Sell |
1,680
-606
| -27% | -$145K | 0.01% | 1501 |
|
|
2025
Q1 | $512K | Buy |
2,286
+180
| +9% | +$42K | 0.01% | 1343 |
|
|
2024
Q4 | $482K | Buy |
2,106
+372
| +21% | +$89.6K | 0.01% | 1350 |
|
|
2024
Q3 | $423K | Sell |
1,734
-134
| -7% | -$29.9K | 0.01% | 1413 |
|
|
2024
Q2 | $357K | Buy |
+1,868
| New | +$379K | ﹤0.01% | 1485 |
|
|
2022
Q3 | – | Sell |
-4,836
| Closed | -$1.01M | – | 782 |
|
|
2022
Q2 | $1.01M | Sell |
4,836
-71
| -1% | -$15.1K | 0.02% | 743 |
|
|
2022
Q1 | $1.19M | Buy |
4,907
+183
| +4% | +$44.3K | 0.02% | 781 |
|
|
2021
Q4 | $1.23M | Buy |
4,724
+640
| +16% | +$166K | 0.02% | 748 |
|
|
2021
Q3 | $1.08M | Buy |
+4,084
| New | +$1.12M | 0.02% | 757 |
|
|
2020
Q3 | – | Sell |
-5,302
| Closed | -$1.02M | – | 597 |
|
|
2020
Q2 | $1.02M | Buy |
+5,302
| New | +$867K | 0.03% | 506 |
|
|
2020
Q1 | – | Sell |
-5,791
| Closed | -$897K | – | 1047 |
|
|
2019
Q4 | $897K | Sell |
5,791
-224
| -4% | -$32.3K | 0.02% | 573 |
|
|
2019
Q3 | $813K | Buy |
6,015
+264
| +5% | +$34.6K | 0.03% | 478 |
|
|
2019
Q2 | $770K | Buy |
5,751
+1,459
| +34% | +$162K | 0.03% | 475 |
|
|
2019
Q1 | $446K | Sell |
4,292
-1,172
| -21% | -$121K | 0.02% | 566 |
|
|
2018
Q4 | $622K | Buy |
5,464
+2,113
| +63% | +$226K | 0.03% | 430 |
|
|
2018
Q3 | $387K | Sell |
3,351
-1,451
| -30% | -$159K | 0.02% | 680 |
|
|
2018
Q2 | $497K | Sell |
4,802
-533
| -10% | -$53.9K | 0.02% | 571 |
|
|
2018
Q1 | $525K | Buy |
5,335
+374
| +8% | +$35.3K | 0.03% | 501 |
|
|
2017
Q4 | $420K | Buy |
4,961
+41
| +0.8% | +$3.39K | 0.02% | 528 |
|
|
2017
Q3 | $379K | Buy |
4,920
+178
| +4% | +$13.6K | 0.02% | 521 |
|
|
2017
Q2 | $369K | Buy |
4,742
+178
| +4% | +$12.7K | 0.02% | 504 |
|
|
2017
Q1 | $328K | Buy |
4,564
+83
| +2% | +$5.74K | 0.02% | 496 |
|
|
2016
Q4 | $278K | Buy |
+4,481
| New | +$274K | 0.02% | 495 |
|
Other funds holding RMD
Atria Investments's RMD Position: Q2 2026 in Review
Atria Investments reduced its ResMed (RMD) stake by 78% in Q2 2026, selling an estimated $775K and leaving 1,031 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #2065.
Atria Investments first reported a position in RMD in Q4 2016 and has held it in 27 quarters since. The position peaked at $1.23M in Q4 2021. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Atria Investments held 1,031 shares of ResMed worth $201K as of Q2 2026.
- Atria Investments sold 3,741 ResMed shares in Q2 2026, an estimated $775K.
- ResMed made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #2065 holding.
- Atria Investments first reported a position in ResMed in Q4 2016 and has held it in 27 quarters since.
- Atria Investments's ResMed position peaked at $1.23M in Q4 2021.
- 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.